185 related articles for article (PubMed ID: 28361856)
21. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
22. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
23. CpG island methylation of TMS1/ASC and CASP8 genes in cervical cancer.
Kordi Tamandani DM; Sobti RC; Shekari M; Huria A
Eur J Med Res; 2009; 14(2):71-5. PubMed ID: 19258216
[TBL] [Abstract][Full Text] [Related]
24. [Promoter methylation and expression of death-associated protein kinase gene in acute leukemia].
Zhao WH; Meng FY; Lai YR; Peng ZG; Ma J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Mar; 37(3):407-410. PubMed ID: 28377362
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.
Narayan G; Freddy AJ; Xie D; Liyanage H; Clark L; Kisselev S; Un Kang J; Nandula SV; McGuinn C; Subramaniyam S; Alobeid B; Satwani P; Savage D; Bhagat G; Murty VV
Genes Chromosomes Cancer; 2011 Dec; 50(12):1043-53. PubMed ID: 21960365
[TBL] [Abstract][Full Text] [Related]
26. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.
Schafer E; Irizarry R; Negi S; McIntyre E; Small D; Figueroa ME; Melnick A; Brown P
Blood; 2010 Jun; 115(23):4798-809. PubMed ID: 20215641
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
[TBL] [Abstract][Full Text] [Related]
29. [Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia].
Qian J; Yao DM; Lin J; Chen Q; Li Y; Ji RB; Yang J; Qian Z; Xiao GF; Wang YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1390-4. PubMed ID: 21176336
[TBL] [Abstract][Full Text] [Related]
30. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
Tsellou E; Troungos C; Moschovi M; Athanasiadou-Piperopoulou F; Polychronopoulou S; Kosmidis H; Kalmanti M; Hatzakis A; Dessypris N; Kalofoutis A; Petridou E
Eur J Cancer; 2005 Mar; 41(4):584-9. PubMed ID: 15737564
[TBL] [Abstract][Full Text] [Related]
32. Hypermethylation of CpG island in the promoter region of CALCA in acute lymphoblastic leukemia with central nervous system (CNS) infiltration correlates with poorer prognosis.
Paixão VA; Vidal DO; Caballero OL; Vettore AL; Tone LG; Ribeiro KB; Lopes LF
Leuk Res; 2006 Jul; 30(7):891-4. PubMed ID: 16712930
[TBL] [Abstract][Full Text] [Related]
33. A Possible Role for WNT5A Hypermethylation in Pediatric Acute Lymphoblastic Leukemia.
Hatırnaz Ng Ö; Fırtına S; Can İ; Karakaş Z; Ağaoğlu L; Doğru Ö; Celkan T; Akçay A; Yıldırmak Y; Timur Ç; Özbek U; Sayitoğlu M
Turk J Haematol; 2015 Jun; 32(2):127-35. PubMed ID: 26316480
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of p15 gene associated with an inferior poor long-term outcome in childhood acute lymphoblastic leukemia.
Mai H; Liu X; Chen Y; Li C; Cao L; Chen X; Chen S; Liu G; Wen F
J Cancer Res Clin Oncol; 2016 Feb; 142(2):497-504. PubMed ID: 26501552
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
36. The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.
Roman-Gomez J; Castillejo JA; Jimenez A; Barrios M; Heiniger A; Torres A
Leuk Lymphoma; 2003 Nov; 44(11):1855-64. PubMed ID: 14738136
[TBL] [Abstract][Full Text] [Related]
37. Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity.
Gordian E; Ramachandran K; Singal R
Anticancer Res; 2009 Aug; 29(8):3207-10. PubMed ID: 19661336
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
39. ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
[TBL] [Abstract][Full Text] [Related]
40. WNT5A, a putative tumour suppressor of lymphoid malignancies, is inactivated by aberrant methylation in acute lymphoblastic leukaemia.
Roman-Gomez J; Jimenez-Velasco A; Cordeu L; Vilas-Zornoza A; San Jose-Eneriz E; Garate L; Castillejo JA; Martin V; Prosper F; Heiniger A; Torres A; Agirre X
Eur J Cancer; 2007 Dec; 43(18):2736-46. PubMed ID: 18032022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]